Nestle divests peanut allergy business Palforzia

has divested its peanut allergy treatment business Palforzia, the Swiss food company said on Monday, following its strategic review of the division.

Nestle said it has offloaded Palforzia to Stallergenes Greer, a biopharmaceutical company which specializes in the diagnosis and treatment of allergies.Reporting by John Revill, Editing by Friederike Heine

الإمارات العربية المتحدة أحدث الأخبار, الإمارات العربية المتحدة عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Nestle divests peanut allergy business Palforzia By ReutersNestle divests peanut allergy business Palforzia
مصدر: Investingcom - 🏆 450. / 53 اقرأ أكثر »

Web3’s Swiss Army knife of personal finance Changex joins Cointelegraph AcceleratorChangex combines crypto trading and lending with traditional banking features that also include an upcoming Visa debit card
مصدر: Cointelegraph - 🏆 562. / 51 اقرأ أكثر »